請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/68013
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳沛隆 | |
dc.contributor.author | Yin-Hung Lin | en |
dc.contributor.author | 林盈宏 | zh_TW |
dc.date.accessioned | 2021-06-17T02:11:14Z | - |
dc.date.available | 2023-02-22 | |
dc.date.copyright | 2018-02-22 | |
dc.date.issued | 2018 | |
dc.date.submitted | 2018-01-17 | |
dc.identifier.citation | 1. Morton, C.C., and Nance, W.E. (2006). Newborn hearing screening--a silent revolution. N Engl J Med 354, 2151-2164.
2. Marazita, M.L., Ploughman, L.M., Rawlings, B., Remington, E., Arnos, K.S., and Nance, W.E. (1993). Genetic epidemiological studies of early-onset deafness in the U.S. school-age population. Am J Med Genet 46, 486-491. 3. Van Camp, G., Willems, P.J., and Smith, R.J. (1997). Nonsyndromic hearing impairment: unparalleled heterogeneity. Am J Hum Genet 60, 758-764. 4. Brownstein, Z., Bhonker, Y., and Avraham, K.B. (2012). High-throughput sequencing to decipher the genetic heterogeneity of deafness. Genome Biol 13, 245. 5. Kenneson, A., Van Naarden Braun, K., and Boyle, C. (2002). GJB2 (connexin 26) variants and nonsyndromic sensorineural hearing loss: a HuGE review. Genet Med 4, 258-274. 6. Hilgert, N., Smith, R.J., and Van Camp, G. (2009). Forty-six genes causing nonsyndromic hearing impairment: which ones should be analyzed in DNA diagnostics? Mutat Res 681, 189-196. 7. Pandya, A., Arnos, K.S., Xia, X.J., Welch, K.O., Blanton, S.H., Friedman, T.B., Garcia Sanchez, G., Liu, M.X., Morell, R., and Nance, W.E. (2003). Frequency and distribution of GJB2 (connexin 26) and GJB6 (connexin 30) mutations in a large North American repository of deaf probands. Genet Med 5, 295-303. 8. Denoyelle, F., Weil, D., Maw, M.A., Wilcox, S.A., Lench, N.J., Allen-Powell, D.R., Osborn, A.H., Dahl, H.H., Middleton, A., Houseman, M.J., et al. (1997). Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. Hum Mol Genet 6, 2173-2177. 9. Frei, K., Szuhai, K., Lucas, T., Weipoltshammer, K., Schofer, C., Ramsebner, R., Baumgartner, W.D., Raap, A.K., Bittner, R., Wachtler, F.J., et al. (2002). Connexin 26 mutations in cases of sensorineural deafness in eastern Austria. Eur J Hum Genet 10, 427-432. 10. Gabriel, H., Kupsch, P., Sudendey, J., Winterhager, E., Jahnke, K., and Lautermann, J. (2001). Mutations in the connexin26/GJB2 gene are the most common event in non-syndromic hearing loss among the German population. Hum Mutat 17, 521-522. 11. Gurtler, N., Kim, Y., Mhatre, A., Muller, R., Probst, R., and Lalwani, A.K. (2003). GJB2 mutations in the Swiss hearing impaired. Ear Hear 24, 440-447. 12. Abe, S., Usami, S., Shinkawa, H., Kelley, P.M., and Kimberling, W.J. (2000). Prevalent connexin 26 gene (GJB2) mutations in Japanese. J Med Genet 37, 41-43. 13. Hwa, H.L., Ko, T.M., Hsu, C.J., Huang, C.H., Chiang, Y.L., Oong, J.L., Chen, C.C., and Hsu, C.K. (2003). Mutation spectrum of the connexin 26 (GJB2) gene in Taiwanese patients with prelingual deafness. Genet Med 5, 161-165. 14. Liu, X.Z., Xia, X.J., Ke, X.M., Ouyang, X.M., Du, L.L., Liu, Y.H., Angeli, S., Telischi, F.F., Nance, W.E., Balkany, T., et al. (2002). The prevalence of connexin 26 (GJB2) mutations in the Chinese population. Hum Genet 111, 394-397. 15. Park, H.J., Hahn, S.H., Chun, Y.M., Park, K., and Kim, H.N. (2000). Connexin26 mutations associated with nonsyndromic hearing loss. Laryngoscope 110, 1535-1538. 16. Dalamon, V., Beheran, A., Diamante, F., Pallares, N., Diamante, V., and Elgoyhen, A.B. (2005). Prevalence of GJB2 mutations and the del(GJB6-D13S1830) in Argentinean non-syndromic deaf patients. Hear Res 207, 43-49. 17. Belintani Piatto, V., Maria Goloni Bertollo, E., Lucia Sartorato, E., and Victor Maniglia, J. (2004). Prevalence of the GJB2 mutations and the del(GJB6-D13S1830) mutation in Brazilian patients with deafness. Hear Res 196, 87-93. 18. Maheshwari, M., Vijaya, R., Ghosh, M., Shastri, S., Kabra, M., and Menon, P.S. (2003). Screening of families with autosomal recessive non-syndromic hearing impairment (ARNSHI) for mutations in GJB2 gene: Indian scenario. Am J Med Genet A 120, 180-184. 19. Morell, R.J., Kim, H.J., Hood, L.J., Goforth, L., Friderici, K., Fisher, R., Van Camp, G., Berlin, C.I., Oddoux, C., Ostrer, H., et al. (1998). Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness. N Engl J Med 339, 1500-1505. 20. Gazzaz, B., Weil, D., Rais, L., Akhyat, O., Azeddoug, H., and Nadifi, S. (2005). Autosomal recessive and sporadic deafness in Morocco: High frequency of the 35delG GJB2 mutation and absence of the 342-kb GJB6 variant. Hear Res. 21. Kalay, E., Caylan, R., Kremer, H., de Brouwer, A.P., and Karaguzel, A. (2005). GJB2 mutations in Turkish patients with ARNSHL: prevalence and two novel mutations. Hear Res 203, 88-93. 22. Alvarez, A., del Castillo, I., Villamar, M., Aguirre, L.A., Gonzalez-Neira, A., Lopez-Nevot, A., Moreno-Pelayo, M.A., and Moreno, F. (2005). High prevalence of the W24X mutation in the gene encoding connexin-26 (GJB2) in Spanish Romani (gypsies) with autosomal recessive non-syndromic hearing loss. Am J Med Genet A 137, 255-258. 23. Campbell, C., Cucci, R.A., Prasad, S., Green, G.E., Edeal, J.B., Galer, C.E., Karniski, L.P., Sheffield, V.C., and Smith, R.J. (2001). Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight novel mutations and possible genotype-phenotype correlations. Hum Mutat 17, 403-411. 24. Tsukamoto, K., Suzuki, H., Harada, D., Namba, A., Abe, S., and Usami, S. (2003). Distribution and frequencies of PDS (SLC26A4) mutations in Pendred syndrome and nonsyndromic hearing loss associated with enlarged vestibular aqueduct: a unique spectrum of mutations in Japanese. Eur J Hum Genet 11, 916-922. 25. Blons, H., Feldmann, D., Duval, V., Messaz, O., Denoyelle, F., Loundon, N., Sergout-Allaoui, A., Houang, M., Duriez, F., Lacombe, D., et al. (2004). Screening of SLC26A4 (PDS) gene in Pendred's syndrome: a large spectrum of mutations in France and phenotypic heterogeneity. Clin Genet 66, 333-340. 26. Albert, S., Blons, H., Jonard, L., Feldmann, D., Chauvin, P., Loundon, N., Sergent-Allaoui, A., Houang, M., Joannard, A., Schmerber, S., et al. (2006). SLC26A4 gene is frequently involved in nonsyndromic hearing impairment with enlarged vestibular aqueduct in Caucasian populations. Eur J Hum Genet 14, 773-779. 27. Park, H.J., Lee, S.J., Jin, H.S., Lee, J.O., Go, S.H., Jang, H.S., Moon, S.K., Lee, S.C., Chun, Y.M., Lee, H.K., et al. (2005). Genetic basis of hearing loss associated with enlarged vestibular aqueducts in Koreans. Clin Genet 67, 160-165. 28. Wu, C.C., Yeh, T.H., Chen, P.J., and Hsu, C.J. (2005). Prevalent SLC26A4 mutations in patients with enlarged vestibular aqueduct and/or Mondini dysplasia: a unique spectrum of mutations in Taiwan, including a frequent founder mutation. Laryngoscope 115, 1060-1064. 29. Hutchin, T.P., Thompson, K.R., Parker, M., Newton, V., Bitner-Glindzicz, M., and Mueller, R.F. (2001). Prevalence of mitochondrial DNA mutations in childhood/congenital onset non-syndromal sensorineural hearing impairment. J Med Genet 38, 229-231. 30. Usami, S., Abe, S., Akita, J., Namba, A., Shinkawa, H., Ishii, M., Iwasaki, S., Hoshino, T., Ito, J., Doi, K., et al. (2000). Prevalence of mitochondrial gene mutations among hearing impaired patients. J Med Genet 37, 38-40. 31. Malik, S.G., Pieter, N., Sudoyo, H., Kadir, A., and Marzuki, S. (2003). Prevalence of the mitochondrial DNA A1555G mutation in sensorineural deafness patients in island Southeast Asia. J Hum Genet 48, 480-483. 32. Wu, C.C., Chiu, Y.H., Chen, P.J., and Hsu, C.J. (2007). Prevalence and clinical features of the mitochondrial m.1555A>G mutation in Taiwanese patients with idiopathic sensorineural hearing loss and association of haplogroup F with low penetrance in three families. Ear Hear 28, 332-342. 33. Coyle, B., Reardon, W., Herbrick, J.A., Tsui, L.C., Gausden, E., Lee, J., Coffey, R., Grueters, A., Grossman, A., Phelps, P.D., et al. (1998). Molecular analysis of the PDS gene in Pendred syndrome. Hum Mol Genet 7, 1105-1112. 34. Park, H.J., Shaukat, S., Liu, X.Z., Hahn, S.H., Naz, S., Ghosh, M., Kim, H.N., Moon, S.K., Abe, S., Tukamoto, K., et al. (2003). Origins and frequencies of SLC26A4 (PDS) mutations in east and south Asians: global implications for the epidemiology of deafness. J Med Genet 40, 242-248. 35. Yuan, Y., Guo, W., Tang, J., Zhang, G., Wang, G., Han, M., Zhang, X., Yang, S., He, D.Z., and Dai, P. (2012). Molecular epidemiology and functional assessment of novel allelic variants of SLC26A4 in non-syndromic hearing loss patients with enlarged vestibular aqueduct in China. PLoS One 7, e49984. 36. Hilgert, N., Smith, R.J., and Van Camp, G. (2009). Forty-six genes causing nonsyndromic hearing impairment: Which ones should be analyzed in DNA diagnostics? Mutat Res. 37. Sanger, F., Nicklen, S., and Coulson, A.R. (1977). DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74, 5463-5467. 38. Metzker, M.L. (2010). Sequencing technologies - the next generation. Nat Rev Genet 11, 31-46. 39. Mardis, E.R. (2011). A decade's perspective on DNA sequencing technology. Nature 470, 198-203. 40. Shearer, A.E., Hildebrand, M.S., Sloan, C.M., and Smith, R.J. (2011). Deafness in the genomics era. Hear Res 282, 1-9. 41. Vona, B., Nanda, I., Hofrichter, M.A., Shehata-Dieler, W., and Haaf, T. (2015). Non-syndromic hearing loss gene identification: A brief history and glimpse into the future. Mol Cell Probes 29, 260-270. 42. Li, Y., Pohl, E., Boulouiz, R., Schraders, M., Nurnberg, G., Charif, M., Admiraal, R.J., von Ameln, S., Baessmann, I., Kandil, M., et al. (2010). Mutations in TPRN cause a progressive form of autosomal-recessive nonsyndromic hearing loss. Am J Hum Genet 86, 479-484. 43. Rehman, A.U., Morell, R.J., Belyantseva, I.A., Khan, S.Y., Boger, E.T., Shahzad, M., Ahmed, Z.M., Riazuddin, S., Khan, S.N., Riazuddin, S., et al. (2010). Targeted capture and next-generation sequencing identifies C9orf75, encoding taperin, as the mutated gene in nonsyndromic deafness DFNB79. Am J Hum Genet 86, 378-388. 44. Walsh, T., Shahin, H., Elkan-Miller, T., Lee, M.K., Thornton, A.M., Roeb, W., Abu Rayyan, A., Loulus, S., Avraham, K.B., King, M.C., et al. (2010). Whole exome sequencing and homozygosity mapping identify mutation in the cell polarity protein GPSM2 as the cause of nonsyndromic hearing loss DFNB82. Am J Hum Genet 87, 90-94. 45. Nyegaard, M., Rendtorff, N.D., Nielsen, M.S., Corydon, T.J., Demontis, D., Starnawska, A., Hedemand, A., Buniello, A., Niola, F., Overgaard, M.T., et al. (2015). A Novel Locus Harbouring a Functional CD164 Nonsense Mutation Identified in a Large Danish Family with Nonsyndromic Hearing Impairment. PLoS Genet 11, e1005386. 46. Zheng, J., Miller, K.K., Yang, T., Hildebrand, M.S., Shearer, A.E., DeLuca, A.P., Scheetz, T.E., Drummond, J., Scherer, S.E., Legan, P.K., et al. (2011). Carcinoembryonic antigen-related cell adhesion molecule 16 interacts with alpha-tectorin and is mutated in autosomal dominant hearing loss (DFNA4). Proc Natl Acad Sci U S A 108, 4218-4223. 47. Chen, D.Y., Liu, X.F., Lin, X.J., Zhang, D., Chai, Y.C., Yu, D.H., Sun, C.L., Wang, X.L., Zhu, W.D., Chen, Y., et al. (2017). A dominant variant in DMXL2 is linked to nonsyndromic hearing loss. Genet Med 19, 553-558. 48. Azaiez, H., Decker, A.R., Booth, K.T., Simpson, A.C., Shearer, A.E., Huygen, P.L., Bu, F., Hildebrand, M.S., Ranum, P.T., Shibata, S.B., et al. (2015). HOMER2, a stereociliary scaffolding protein, is essential for normal hearing in humans and mice. PLoS Genet 11, e1005137. 49. Zazo Seco, C., Serrao de Castro, L., van Nierop, J.W., Morin, M., Jhangiani, S., Verver, E.J., Schraders, M., Maiwald, N., Wesdorp, M., Venselaar, H., et al. (2015). Allelic Mutations of KITLG, Encoding KIT Ligand, Cause Asymmetric and Unilateral Hearing Loss and Waardenburg Syndrome Type 2. Am J Hum Genet 97, 647-660. 50. Gao, J., Wang, Q., Dong, C., Chen, S., Qi, Y., and Liu, Y. (2015). Whole Exome Sequencing Identified MCM2 as a Novel Causative Gene for Autosomal Dominant Nonsyndromic Deafness in a Chinese Family. PLoS One 10, e0133522. 51. Yan, D., Zhu, Y., Walsh, T., Xie, D., Yuan, H., Sirmaci, A., Fujikawa, T., Wong, A.C., Loh, T.L., Du, L., et al. (2013). Mutation of the ATP-gated P2X(2) receptor leads to progressive hearing loss and increased susceptibility to noise. Proc Natl Acad Sci U S A 110, 2228-2233. 52. Xing, G., Yao, J., Wu, B., Liu, T., Wei, Q., Liu, C., Lu, Y., Chen, Z., Zheng, H., Yang, X., et al. (2015). Identification of OSBPL2 as a novel candidate gene for progressive nonsyndromic hearing loss by whole-exome sequencing. Genet Med 17, 210-218. 53. Thoenes, M., Zimmermann, U., Ebermann, I., Ptok, M., Lewis, M.A., Thiele, H., Morlot, S., Hess, M.M., Gal, A., Eisenberger, T., et al. (2015). OSBPL2 encodes a protein of inner and outer hair cell stereocilia and is mutated in autosomal dominant hearing loss (DFNA67). Orphanet J Rare Dis 10, 15. 54. Zhao, Y., Zhao, F., Zong, L., Zhang, P., Guan, L., Zhang, J., Wang, D., Wang, J., Chai, W., Lan, L., et al. (2013). Exome sequencing and linkage analysis identified tenascin-C (TNC) as a novel causative gene in nonsyndromic hearing loss. PLoS One 8, e69549. 55. Santos-Cortez, R.L., Lee, K., Giese, A.P., Ansar, M., Amin-Ud-Din, M., Rehn, K., Wang, X., Aziz, A., Chiu, I., Hussain Ali, R., et al. (2014). Adenylate cyclase 1 (ADCY1) mutations cause recessive hearing impairment in humans and defects in hair cell function and hearing in zebrafish. Hum Mol Genet 23, 3289-3298. 56. Girotto, G., Abdulhadi, K., Buniello, A., Vozzi, D., Licastro, D., d'Eustacchio, A., Vuckovic, D., Alkowari, M.K., Steel, K.P., Badii, R., et al. (2013). Linkage study and exome sequencing identify a BDP1 mutation associated with hereditary hearing loss. PLoS One 8, e80323. 57. Schrauwen, I., Helfmann, S., Inagaki, A., Predoehl, F., Tabatabaiefar, M.A., Picher, M.M., Sommen, M., Zazo Seco, C., Oostrik, J., Kremer, H., et al. (2012). A mutation in CABP2, expressed in cochlear hair cells, causes autosomal-recessive hearing impairment. Am J Hum Genet 91, 636-645. 58. Delmaghani, S., Aghaie, A., Bouyacoub, Y., El Hachmi, H., Bonnet, C., Riahi, Z., Chardenoux, S., Perfettini, I., Hardelin, J.P., Houmeida, A., et al. (2016). Mutations in CDC14A, Encoding a Protein Phosphatase Involved in Hair Cell Ciliogenesis, Cause Autosomal-Recessive Severe to Profound Deafness. Am J Hum Genet 98, 1266-1270. 59. Seco, C.Z., Oonk, A.M., Dominguez-Ruiz, M., Draaisma, J.M., Gandia, M., Oostrik, J., Neveling, K., Kunst, H.P., Hoefsloot, L.H., del Castillo, I., et al. (2015). Progressive hearing loss and vestibular dysfunction caused by a homozygous nonsense mutation in CLIC5. Eur J Hum Genet 23, 189-194. 60. Grati, M., Chakchouk, I., Ma, Q., Bensaid, M., Desmidt, A., Turki, N., Yan, D., Baanannou, A., Mittal, R., Driss, N., et al. (2015). A missense mutation in DCDC2 causes human recessive deafness DFNB66, likely by interfering with sensory hair cell and supporting cell cilia length regulation. Hum Mol Genet 24, 2482-2491. 61. Jaworek, T.J., Richard, E.M., Ivanova, A.A., Giese, A.P., Choo, D.I., Khan, S.N., Riazuddin, S., Kahn, R.A., and Riazuddin, S. (2013). An alteration in ELMOD3, an Arl2 GTPase-activating protein, is associated with hearing impairment in humans. PLoS Genet 9, e1003774. 62. Behlouli, A., Bonnet, C., Abdi, S., Bouaita, A., Lelli, A., Hardelin, J.P., Schietroma, C., Rous, Y., Louha, M., Cheknane, A., et al. (2014). EPS8, encoding an actin-binding protein of cochlear hair cell stereocilia, is a new causal gene for autosomal recessive profound deafness. Orphanet J Rare Dis 9, 55. 63. Dahmani, M., Ammar-Khodja, F., Bonnet, C., Lefevre, G.M., Hardelin, J.P., Ibrahim, H., Mallek, Z., and Petit, C. (2015). EPS8L2 is a new causal gene for childhood onset autosomal recessive progressive hearing loss. Orphanet J Rare Dis 10, 96. 64. Diaz-Horta, O., Subasioglu-Uzak, A., Grati, M., DeSmidt, A., Foster, J., 2nd, Cao, L., Bademci, G., Tokgoz-Yilmaz, S., Duman, D., Cengiz, F.B., et al. (2014). FAM65B is a membrane-associated protein of hair cell stereocilia required for hearing. Proc Natl Acad Sci U S A 111, 9864-9868. 65. Imtiaz, A., Kohrman, D.C., and Naz, S. (2014). A frameshift mutation in GRXCR2 causes recessively inherited hearing loss. Hum Mutat 35, 618-624. 66. Santos-Cortez, R.L., Lee, K., Azeem, Z., Antonellis, P.J., Pollock, L.M., Khan, S., Irfanullah, Andrade-Elizondo, P.B., Chiu, I., Adams, M.D., et al. (2013). Mutations in KARS, encoding lysyl-tRNA synthetase, cause autosomal-recessive nonsyndromic hearing impairment DFNB89. Am J Hum Genet 93, 132-140. 67. Mujtaba, G., Schultz, J.M., Imtiaz, A., Morell, R.J., Friedman, T.B., and Naz, S. (2015). A mutation of MET, encoding hepatocyte growth factor receptor, is associated with human DFNB97 hearing loss. J Med Genet 52, 548-552. 68. Simon, M., Richard, E.M., Wang, X., Shahzad, M., Huang, V.H., Qaiser, T.A., Potluri, P., Mahl, S.E., Davila, A., Nazli, S., et al. (2015). Mutations of human NARS2, encoding the mitochondrial asparaginyl-tRNA synthetase, cause nonsyndromic deafness and Leigh syndrome. PLoS Genet 11, e1005097. 69. Yariz, K.O., Duman, D., Zazo Seco, C., Dallman, J., Huang, M., Peters, T.A., Sirmaci, A., Lu, N., Schraders, M., Skromne, I., et al. (2012). Mutations in OTOGL, encoding the inner ear protein otogelin-like, cause moderate sensorineural hearing loss. Am J Hum Genet 91, 872-882. 70. Diaz-Horta, O., Abad, C., Sennaroglu, L., Foster, J., 2nd, DeSmidt, A., Bademci, G., Tokgoz-Yilmaz, S., Duman, D., Cengiz, F.B., Grati, M., et al. (2016). ROR1 is essential for proper innervation of auditory hair cells and hearing in humans and mice. Proc Natl Acad Sci U S A 113, 5993-5998. 71. Santos-Cortez, R.L., Faridi, R., Rehman, A.U., Lee, K., Ansar, M., Wang, X., Morell, R.J., Isaacson, R., Belyantseva, I.A., Dai, H., et al. (2016). Autosomal-Recessive Hearing Impairment Due to Rare Missense Variants within S1PR2. Am J Hum Genet 98, 331-338. 72. Ben Said, M., Grati, M., Ishimoto, T., Zou, B., Chakchouk, I., Ma, Q., Yao, Q., Hammami, B., Yan, D., Mittal, R., et al. (2016). A mutation in SLC22A4 encoding an organic cation transporter expressed in the cochlea strial endothelium causes human recessive non-syndromic hearing loss DFNB60. Hum Genet 135, 513-524. 73. Li, J., Zhao, X., Xin, Q., Shan, S., Jiang, B., Jin, Y., Yuan, H., Dai, P., Xiao, R., Zhang, Q., et al. (2015). Whole-exome sequencing identifies a variant in TMEM132E causing autosomal-recessive nonsyndromic hearing loss DFNB99. Hum Mutat 36, 98-105. 74. Delmaghani, S., Aghaie, A., Michalski, N., Bonnet, C., Weil, D., and Petit, C. (2012). Defect in the gene encoding the EAR/EPTP domain-containing protein TSPEAR causes DFNB98 profound deafness. Hum Mol Genet 21, 3835-3844. 75. Buniello, A., Ingham, N.J., Lewis, M.A., Huma, A.C., Martinez-Vega, R., Varela-Nieto, I., Vizcay-Barrena, G., Fleck, R.A., Houston, O., Bardhan, T., et al. (2016). Wbp2 is required for normal glutamatergic synapses in the cochlea and is crucial for hearing. EMBO Mol Med 8, 191-207. 76. Rehman, A.U., Santos-Cortez, R.L., Morell, R.J., Drummond, M.C., Ito, T., Lee, K., Khan, A.A., Basra, M.A., Wasif, N., Ayub, M., et al. (2014). Mutations in TBC1D24, a gene associated with epilepsy, also cause nonsyndromic deafness DFNB86. Am J Hum Genet 94, 144-152. 77. Azaiez, H., Booth, K.T., Bu, F., Huygen, P., Shibata, S.B., Shearer, A.E., Kolbe, D., Meyer, N., Black-Ziegelbein, E.A., and Smith, R.J. (2014). TBC1D24 mutation causes autosomal-dominant nonsyndromic hearing loss. Hum Mutat 35, 819-823. 78. Zhang, L., Hu, L., Chai, Y., Pang, X., Yang, T., and Wu, H. (2014). A dominant mutation in the stereocilia-expressing gene TBC1D24 is a probable cause for nonsyndromic hearing impairment. Hum Mutat 35, 814-818. 79. Zong, L., Guan, J., Ealy, M., Zhang, Q., Wang, D., Wang, H., Zhao, Y., Shen, Z., Campbell, C.A., Wang, F., et al. (2015). Mutations in apoptosis-inducing factor cause X-linked recessive auditory neuropathy spectrum disorder. J Med Genet 52, 523-531. 80. Rost, S., Bach, E., Neuner, C., Nanda, I., Dysek, S., Bittner, R.E., Keller, A., Bartsch, O., Mlynski, R., Haaf, T., et al. (2014). Novel form of X-linked nonsyndromic hearing loss with cochlear malformation caused by a mutation in the type IV collagen gene COL4A6. Eur J Hum Genet 22, 208-215. 81. Schraders, M., Haas, S.A., Weegerink, N.J., Oostrik, J., Hu, H., Hoefsloot, L.H., Kannan, S., Huygen, P.L., Pennings, R.J., Admiraal, R.J., et al. (2011). Next-generation sequencing identifies mutations of SMPX, which encodes the small muscle protein, X-linked, as a cause of progressive hearing impairment. Am J Hum Genet 88, 628-634. 82. Huebner, A.K., Gandia, M., Frommolt, P., Maak, A., Wicklein, E.M., Thiele, H., Altmuller, J., Wagner, F., Vinuela, A., Aguirre, L.A., et al. (2011). Nonsense mutations in SMPX, encoding a protein responsive to physical force, result in X-chromosomal hearing loss. Am J Hum Genet 88, 621-627. 83. Shearer, A.E., Deluca, A.P., Hildebrand, M.S., Taylor, K.R., Gurrola, J., 2nd, Scherer, S., Scheetz, T.E., and Smith, R.J. (2010). Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc Natl Acad Sci U S A 107, 21104-21109. 84. Wu, C.C., Chen, P.J., Chiu, Y.H., Lu, Y.C., Wu, M.C., and Hsu, C.J. (2008). Prospective mutation screening of three common deafness genes in a large Taiwanese Cohort with idiopathic bilateral sensorineural hearing impairment reveals a difference in the results between families from hospitals and those from rehabilitation facilities. Audiol Neurootol 13, 172-181. 85. Van Esch, H., Groenen, P., Nesbit, M.A., Schuffenhauer, S., Lichtner, P., Vanderlinden, G., Harding, B., Beetz, R., Bilous, R.W., Holdaway, I., et al. (2000). GATA3 haplo-insufficiency causes human HDR syndrome. Nature 406, 419-422. 86. Upadhyay, J., Steenkamp, D.W., and Milunsky, J.M. (2013). The syndrome of hypoparathyroidism, deafness, and renal anomalies. Endocr Pract 19, 1035-1042. 87. Urban, Z., Michels, V.V., Thibodeau, S.N., Davis, E.C., Bonnefont, J.P., Munnich, A., Eyskens, B., Gewillig, M., Devriendt, K., and Boyd, C.D. (2000). Isolated supravalvular aortic stenosis: functional haploinsufficiency of the elastin gene as a result of nonsense-mediated decay. Hum Genet 106, 577-588. 88. Bouligand, J., Delemer, B., Hecart, A.C., Meduri, G., Viengchareun, S., Amazit, L., Trabado, S., Feve, B., Guiochon-Mantel, A., Young, J., et al. (2010). Familial glucocorticoid receptor haploinsufficiency by non-sense mediated mRNA decay, adrenal hyperplasia and apparent mineralocorticoid excess. PLoS One 5, e13563. 89. Shearer, A.E., and Smith, R.J. (2015). Massively Parallel Sequencing for Genetic Diagnosis of Hearing Loss: The New Standard of Care. Otolaryngol Head Neck Surg 153, 175-182. 90. Sloan-Heggen, C.M., Bierer, A.O., Shearer, A.E., Kolbe, D.L., Nishimura, C.J., Frees, K.L., Ephraim, S.S., Shibata, S.B., Booth, K.T., Campbell, C.A., et al. (2016). Comprehensive genetic testing in the clinical evaluation of 1119 patients with hearing loss. Hum Genet 135, 441-450. 91. Vahava, O., Morell, R., Lynch, E.D., Weiss, S., Kagan, M.E., Ahituv, N., Morrow, J.E., Lee, M.K., Skvorak, A.B., Morton, C.C., et al. (1998). Mutation in transcription factor POU4F3 associated with inherited progressive hearing loss in humans. Science 279, 1950-1954. 92. Collin, R.W., Chellappa, R., Pauw, R.J., Vriend, G., Oostrik, J., van Drunen, W., Huygen, P.L., Admiraal, R., Hoefsloot, L.H., Cremers, F.P., et al. (2008). Missense mutations in POU4F3 cause autosomal dominant hearing impairment DFNA15 and affect subcellular localization and DNA binding. Hum Mutat 29, 545-554. 93. Pauw, R.J., van Drunen, F.J., Collin, R.W., Huygen, P.L., Kremer, H., and Cremers, C.W. (2008). Audiometric characteristics of a Dutch family linked to DFNA15 with a novel mutation (p.L289F) in POU4F3. Arch Otolaryngol Head Neck Surg 134, 294-300. 94. Baek, J.I., Oh, S.K., Kim, D.B., Choi, S.Y., Kim, U.K., Lee, K.Y., and Lee, S.H. (2012). Targeted massive parallel sequencing: the effective detection of novel causative mutations associated with hearing loss in small families. Orphanet J Rare Dis 7, 60. 95. Kim, H.J., Won, H.H., Park, K.J., Hong, S.H., Ki, C.S., Cho, S.S., Venselaar, H., Vriend, G., and Kim, J.W. (2013). SNP linkage analysis and whole exome sequencing identify a novel POU4F3 mutation in autosomal dominant late-onset nonsyndromic hearing loss (DFNA15). PLoS One 8, e79063. 96. Miyagawa, M., Naito, T., Nishio, S.Y., Kamatani, N., and Usami, S. (2013). Targeted exon sequencing successfully discovers rare causative genes and clarifies the molecular epidemiology of Japanese deafness patients. PLoS One 8, e71381. 97. Wei, Q., Zhu, H., Qian, X., Chen, Z., Yao, J., Lu, Y., Cao, X., and Xing, G. (2014). Targeted genomic capture and massively parallel sequencing to identify novel variants causing Chinese hereditary hearing loss. J Transl Med 12, 311. 98. Lee, H.K., Park, H.J., Lee, K.Y., Park, R., and Kim, U.K. (2010). A novel frameshift mutation of POU4F3 gene associated with autosomal dominant non-syndromic hearing loss. Biochem Biophys Res Commun 396, 626-630. 99. Mutai, H., Suzuki, N., Shimizu, A., Torii, C., Namba, K., Morimoto, N., Kudoh, J., Kaga, K., Kosaki, K., and Matsunaga, T. (2013). Diverse spectrum of rare deafness genes underlies early-childhood hearing loss in Japanese patients: a cross-sectional, multi-center next-generation sequencing study. Orphanet J Rare Dis 8, 172. 100. Yang, T., Wei, X., Chai, Y., Li, L., and Wu, H. (2013). Genetic etiology study of the non-syndromic deafness in Chinese Hans by targeted next-generation sequencing. Orphanet J Rare Dis 8, 85. 101. Cai, X.Z., Li, Y., Xia, L., Peng, Y., He, C.F., Jiang, L., Feng, Y., Xia, K., Liu, X.Z., Mei, L.Y., et al. (2017). Exome sequencing identifies POU4F3 as the causative gene for a large Chinese family with non-syndromic hearing loss. J Hum Genet 62, 317-320. 102. Freitas, E.L., Oiticica, J., Silva, A.G., Bittar, R.S., Rosenberg, C., and Mingroni-Netto, R.C. (2014). Deletion of the entire POU4F3 gene in a familial case of autosomal dominant non-syndromic hearing loss. Eur J Med Genet 57, 125-128. 103. Rosenberg, C., Freitas, E.L., Uehara, D.T., Auricchio, M.T., Costa, S.S., Oiticica, J., Silva, A.G., Krepischi, A.C., and Mingroni-Netto, R.C. (2015). Clinical Genetics Genomic copy number alterations in non-syndromic hearing loss. Clin Genet 89, 473-477. 104. Gerrero, M.R., McEvilly, R.J., Turner, E., Lin, C.R., O'Connell, S., Jenne, K.J., Hobbs, M.V., and Rosenfeld, M.G. (1993). Brn-3.0: a POU-domain protein expressed in the sensory, immune, and endocrine systems that functions on elements distinct from known octamer motifs. Proc Natl Acad Sci U S A 90, 10841-10845. 105. Weiss, S., Gottfried, I., Mayrose, I., Khare, S.L., Xiang, M., Dawson, S.J., and Avraham, K.B. (2003). The DFNA15 deafness mutation affects POU4F3 protein stability, localization, and transcriptional activity. Mol Cell Biol 23, 7957-7964. 106. Wu, C.C., Chen, Y.S., Chen, P.J., and Hsu, C.J. (2005). Common clinical features of children with enlarged vestibular aqueduct and mondini dysplasia. Laryngoscope 115, 132-137. 107. Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W.W., Hegde, M., Lyon, E., Spector, E., et al. (2015). Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17, 405-424. 108. Robbins, J., Dilworth, S.M., Laskey, R.A., and Dingwall, C. (1991). Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell 64, 615-623. 109. Hutchins, E.J., Belrose, J.L., and Szaro, B.G. (2016). A novel role for the nuclear localization signal in regulating hnRNP K protein stability in vivo. Biochem Biophys Res Commun 478, 772-776. 110. An, L., Jiang, Y., Ng, H.H., Man, E.P., Chen, J., Khoo, U.S., Gong, Q., and Huen, M.S. (2017). Dual-utility NLS drives RNF169-dependent DNA damage responses. Proc Natl Acad Sci U S A 114, E2872-E2881. 111. Wilkie, A.O. (1994). The molecular basis of genetic dominance. J Med Genet 31, 89-98. 112. Keithley, E.M., Erkman, L., Bennett, T., Lou, L., and Ryan, A.F. (1999). Effects of a hair cell transcription factor, Brn-3.1, gene deletion on homozygous and heterozygous mouse cochleas in adulthood and aging. Hear Res 134, 71-76. 113. Klauer, A.A., and van Hoof, A. (2012). Degradation of mRNAs that lack a stop codon: a decade of nonstop progress. Wiley Interdiscip Rev RNA 3, 649-660. 114. Nadol, J.B., Jr. (1993). Hearing loss. N Engl J Med 329, 1092-1102. 115. Niparko, J.K., Tobey, E.A., Thal, D.J., Eisenberg, L.S., Wang, N.Y., Quittner, A.L., and Fink, N.E. (2010). Spoken language development in children following cochlear implantation. JAMA 303, 1498-1506. 116. Nikolopoulos, T.P., O'Donoghue, G.M., and Archbold, S. (1999). Age at implantation: its importance in pediatric cochlear implantation. Laryngoscope 109, 595-599. 117. Waltzman, S.B., and Roland, J.T., Jr. (2005). Cochlear implantation in children younger than 12 months. Pediatrics 116, e487-493. 118. Cullen, R.D., Higgins, C., Buss, E., Clark, M., Pillsbury, H.C., 3rd, and Buchman, C.A. (2004). Cochlear implantation in patients with substantial residual hearing. Laryngoscope 114, 2218-2223. 119. Papsin, B.C. (2005). Cochlear implantation in children with anomalous cochleovestibular anatomy. Laryngoscope 115, 1-26. 120. Walton, J., Gibson, W.P., Sanli, H., and Prelog, K. (2008). Predicting cochlear implant outcomes in children with auditory neuropathy. Otol Neurotol 29, 302-309. 121. Dahl, H.H., Wake, M., Sarant, J., Poulakis, Z., Siemering, K., and Blamey, P. (2003). Language and speech perception outcomes in hearing-impaired children with and without connexin 26 mutations. Audiol Neurootol 8, 263-268. 122. Wu, C.C., Lee, Y.C., Chen, P.J., and Hsu, C.J. (2008). Predominance of genetic diagnosis and imaging results as predictors in determining the speech perception performance outcome after cochlear implantation in children. Arch Pediatr Adolesc Med 162, 269-276. 123. Tono, T., Ushisako, Y., Kiyomizu, K., Usami, S., Abe, S., Shinkawa, H., and Komune, S. (1998). Cochlear implantation in a patient with profound hearing loss with the A1555G mitochondrial mutation. Am J Otol 19, 754-757. 124. Rouillon, I., Marcolla, A., Roux, I., Marlin, S., Feldmann, D., Couderc, R., Jonard, L., Petit, C., Denoyelle, F., Garabedian, E.N., et al. (2006). Results of cochlear implantation in two children with mutations in the OTOF gene. Int J Pediatr Otorhinolaryngol 70, 689-696. 125. Wu, C.C., Liu, T.C., Wang, S.H., Hsu, C.J., and Wu, C.M. (2011). Genetic characteristics in children with cochlear implants and the corresponding auditory performance. Laryngoscope 121, 1287-1293. 126. Eppsteiner, R.W., Shearer, A.E., Hildebrand, M.S., Deluca, A.P., Ji, H., Dunn, C.C., Black-Ziegelbein, E.A., Casavant, T.L., Braun, T.A., Scheetz, T.E., et al. (2012). Prediction of cochlear implant performance by genetic mutation: the spiral ganglion hypothesis. Hear Res 292, 51-58. 127. Mohr, P.E., Feldman, J.J., Dunbar, J.L., McConkey-Robbins, A., Niparko, J.K., Rittenhouse, R.K., and Skinner, M.W. (2000). The societal costs of severe to profound hearing loss in the United States. Int J Technol Assess Health Care 16, 1120-1135. 128. Archbold, S.M., Nikolopoulos, T.P., and Lloyd-Richmond, H. (2009). Long-term use of cochlear implant systems in paediatric recipients and factors contributing to non-use. Cochlear Implants Int 10, 25-40. 129. Raine, C.H., Summerfield, Q., Strachan, D.R., Martin, J.M., and Totten, C. (2008). The cost and analysis of nonuse of cochlear implants. Otol Neurotol 29, 221-224. 130. Fang, H.Y., Ko, H.C., Wang, N.M., Fang, T.J., Chao, W.C., Tsou, Y.T., and Wu, C.M. (2014). Auditory performance and speech intelligibility of Mandarin-speaking children implanted before age 5. Int J Pediatr | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/68013 | - |
dc.description.abstract | 感音型聽損是人類最常見的感覺缺陷。根據統計,每 1000 名兒童中約有三人患有感音型聽損。其中,百分之六十的病患可歸因於遺傳因素,稱作遺傳性聽損。遺傳性聽損是一種基因異質性非常高的疾病,目前已知有超過 100 個基因,5000多個變異點位與聽損有關。過去研究發現,利用 Sanger 定序技術,針對常見的聽損基因做檢測,只有約三分之一的聽損家族能夠達成診斷。剩下約三分之二的家族,受限於聽損基因的數量與 Sanger 定序所需耗費的大量人力與成本,造成分子診斷上的困難。近年來,次世代定序技術的興起突破了此一瓶頸,使得聽損家族能夠接受更完整的基因檢測。
本研究中,我們利用次世代定序技術,建立一個包含 159 個聽損基因的檢測平台。我們使用 Illumina MiSeq 定序儀器,產生讀長為 300 個鹼基對的雙端定序。我們建立了自動化的生物資訊分析流程並整合相關的疾病資料庫,進行定序結果的分析與判讀。利用此一次世代定序聽損基因檢測平台,我們探討了數個目前尚未解決的問題,簡述如下: (一) 診斷常見聽損基因檢測未能達成診斷之病人 我們針對 246 個未能經由常見聽損基因檢測達成診斷之家族,進行次世代定序基因檢測。我們確定了 101 個家族共 24 個致病基因,診斷率為 41%。我們在一個聽損家族中發現 GATA3 基因 c.153delT 變異。在另一個聽損家族中,我們發現 POU4F3 基因 p.Lys328Glu變異。這兩個變異皆為未曾於文獻上發表的新變異點位。同時,我們進行了功能性的研究探討這兩個新發現的基因變異之致病原因與機轉。 (二) 診斷人工耳蝸植入成效不彰之病童 人工耳蝸是目前重度與極重度聽損病童之治療方式。然而,人工耳蝸植入的效果在不同的病童間差異很大。我們選取了 12 個人工耳蝸植入成效不彰的病童與 30 個植入效果好的病童進行次世代定序基因檢測。我們發現人工耳蝸植入成效不彰的病童帶有DFNB59 基因 p.G292R 變異,可作為人工耳蝸植入成效的標記。 (三) 診斷不帶有兩個 SLC26A4 常見基因變異的大前庭導水管症候群病人 大前庭導水管症候群是常見的內耳畸形,主要由同時帶有兩個 SLC26A4 基因變異所導致。我們選取 50 個不帶有兩個 SLC26A4 常見基因變異 (c.919-2A>G 與 p.H723R) 的家族進行次世代定序基因檢測,我們在 34 個家族當中找到兩個 SLC26A4 基因變異,包括一個 SLC26A4 基因的大片段缺失。我們發現另外兩個家族帶有 EYA1 基因變異,達成了 72% 的診斷率。 (四) 診斷只帶有單一GJB2 基因變異的隱性遺傳模式聽損家族以及基因型和表現型不吻合之 GJB2 基因變異病人 大多數的GJB2 基因變異會導致隱性遺傳模式的聽損。但臨床上發現有部分病人只能找到一個 GJB2 基因變異,造成診斷上的困難,此外,部分帶有導致輕度到中度聽損的 GJB2 基因 p.V37I 變異病人呈現重度與極重度的聽損,成為診斷上的難題。我們選取了 16 個只帶有一個 GJB2 基因變異的病人與 22 個 GJB2 基因 p.V37I 變異的病人,進行次世代定序基因檢測。我們達成了七位只帶有一個 GJB2 基因變異的病人的基因診斷,包括五位病人帶有其他的聽損基因致病點位,一位病人帶有 GJB2 基因剪接位點上的變異點位,與一位為 GJB2 基因 c.235delC 變異鑲嵌型的病人。在 GJB2 基因 p.V37I 變異的病人當中,我們發現一位病人帶有 TMC1 的基因變異,解釋了其重度與極重度聽損的原因。 | zh_TW |
dc.description.abstract | Sensorineural hearing impairment (SNHI) is the most common sensory deficit in humans, affecting about three per 1000 children. More than 60% of these patients have a genetic cause (i.e. hereditary hearing impairment; HHI). HHI is extremely heterogeneous, with approximately 5000 variants in more than 100 genes reported as causative variants to date. Studies across different populations revealed that hotspots screening of common deafness genes (e.g. GJB2, SLC26A4 and the mitochondrial 12S rRNA) using Sanger sequencing could only achieve genetic diagnosis in ~1/3 hearing-impaired families. Recently, the advent of next-generation sequencing (NGS) has revolutionized the clinical evaluation of hearing-impaired patients by making comprehensive genetic testing possible.
In this study, we established an NGS-based diagnostic platform for HHI. A capture-based panel was designed to target 159 deafness genes. Sequencing was performed by Illumina MiSeq which generated paired-end reads of 300 nucleotides. We developed an automated bioinformatics pipeline for analyzing the sequencing data. Disease and gene-specific databases have been curated and built to enable automatic matching. We have explored several unsolved problems of genetic basis of HHI as follows: (1) Diagnosis of patients without common deafness-causing variants We subjected 246 hearing-impaired families to our NGS-based diagnostic platform. We identified causative variants in 24 genes in 101 families, yielding a diagnostic rate of 41%. We identified a novel GATA3 pathogenic variant (c.153delT, p.Phe51Leufs*144) in one family. In another family, we identified a novel missense variant of POU4F3 (c.982A>G, p.Lys328Glu) which co-segregated with the deafness phenotype. We performed function studies for these two novel variants and explored the underlying mechanism. (2) Diagnosis of hearing-impaired children with poor cochlear implantation outcomes Cochlear implantation is currently the treatment of choice for children with severe to profound hearing impairment. However, the outcomes with cochlear implants (CIs) vary significantly among recipients. Twelve children with poor CI outcomes (the “cases”) and 30 “matched controls” with good CI outcomes were subjected to the NGS-based diagnosis platform. We identified DFNB59 p.G292R which might be associated with poor CI outcomes. (3) Diagnosis of enlarged vestibular aqueduct patients without bi-allelic SLC26A4 hotspots Enlarged vestibular aqueduct (EVA) is a common inner ear malformation caused mainly by bi-allelic SLC26A4 variants. We performed the NGS-based diagnostic platform in 50 families without confirmative results by screening two SLC26A4 hotspots (c.919-2A>G and p.H723R). We identified bi-allelic SLC26A4 pathogenic variants (including a large SLC26A4 deletion) in 34 families and EYA1 causative variants in two families, yielding a diagnostic rate of 72% (36/50). (4) Diagnosis of hearing-impaired patients with non-confirmative or genotype–phenotype-mismatched GJB2 pathogenic variants A significant percentage of patients segregate only one variant causing autosomal recessive SNHI in the GJB2. In addition, some patients with mild GJB2 variants such as p.V37I develop severe-to-profound SNHI. We performed NGS in 16 patients with mono-allelic GJB2 pathogenic variant and 22 patients with homozygous GJB2 p.V37I who had SNHI of varied severity. We confirmed the genetic diagnosis in seven patients with a GJB2 pathogenic variant. Of these, five patients had causative variants in other deafness genes; one patient had a splice site variant in the second GJB2 allele; and one patient had ~69% mosaicism for GJB2 c.235delC because of mosaic uniparental disomy. One patient homozygous for p.V37I had causative variants in TMC1, which might be responsible for the severe-to-profound SNHI. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T02:11:14Z (GMT). No. of bitstreams: 1 ntu-107-D03455003-1.pdf: 3928617 bytes, checksum: 059236de9619e33166da12b7161f592f (MD5) Previous issue date: 2018 | en |
dc.description.tableofcontents | 誌謝 i
中文摘要 ii Abstract iv Table of Contents vii List of Figures xi List of Tables xii 1 Introduction 1 1.1 Genetic studies for hereditary hearing impairment 1 1.1.1 Hereditary hearing impairment 1 1.1.2 Deafness genes 1 1.2 Next-generation sequencing (NGS) in genetic studies of HHI 2 1.2.1 Introduction of NGS 2 1.2.2 Using NGS to search for novel deafness genes 3 1.2.3 Using NGS for clinical diagnosis of HHI 3 1.3 The purpose of this study 5 2 Establishment of an NGS-based diagnostic platform for HHI 6 2.1 Developing a targeted deafness panel for DNA sequencing 6 2.2 Building an automated pipeline for analyzing the sequencing data 6 2.3 Diagnosis of patients without common deafness-causing variants 7 3 Identification of a novel GATA3 pathogenic variant in a deaf Taiwanese family 13 3.1 Background 13 3.2 Methods 13 3.2.1 Subjects and clinical evaluations 13 3.2.2 RNA extraction, cDNA synthesis and sequencing 14 3.3 Results 14 3.3.1 Variant detection 14 3.3.2 Clinical examination 14 3.3.3 Nonsense-mediated mRNA decay 15 3.4 Discussion 18 4 A novel missense variant in the nuclear localization signal of POU4F3 causes autosomal dominant non-syndromic SNHI 19 4.1 Background 19 4.2 Methods 20 4.2.1 Subjects and clinical evaluation 20 4.2.2 Cell transfection and immunocytochemistry 20 4.3 Results 22 4.3.1 Clinical features 22 4.3.2 Identification of the causative variant 22 4.3.3 Effect of p.Lys328Glu on subcellular localization of POU4F3 23 4.3.4 Pathogenicity of POU4F3 p.Lys328Glu 23 4.3.5 Prevalence of POU4F3 variants in hearing-impaired families 25 4.4 Discussion 26 5 Diagnosis of hearing-impaired children with poor cochlear implantation outcomes 29 5.1 Background 29 5.2 Methods 30 5.2.1 Subjects and clinical evaluations 30 5.2.2 Evaluation of auditory and speech performance 31 5.2.3 Analyses of Genotypes and Phenotypes 33 5.3 Results 33 5.3.1 Demographic characteristic 33 5.3.2 Identification of genetic variants 33 5.3.3 Comparison of variant frequencies between cases and controls 36 5.3.4 Clinical features and CI outcomes in patients with DFNB59 variants 36 5.4 Discussion 38 6 Diagnosis of enlarged vestibular aqueduct patients without bi-allelic SLC26A4 hotspots 40 6.1 Background 40 6.2 Methods 41 6.2.1 Subject recruitment and phenotype characterization 41 6.2.2 Copy number variation (CNV) detection 42 6.3 Results 42 6.3.1 Genetic examination of SLC26A4 by the NGS-based diagnostic platform 42 6.3.2 CNV identified in SLC26A4 46 6.3.3 Non-coding regions of SLC26A4 48 6.3.4 Pathogenic variants identified in EYA1 48 6.3.5 Variants identified in other EVA-related genes 49 6.4 Discussion 52 7 Diagnosis of hearing-impaired patients with non-confirmative or genotype–phenotype-mismatched GJB2 pathogenic variants 56 7.1 Background 56 7.2 Methods 57 7.2.1 Subjects 57 7.2.2 Characterization of phenotypes 59 7.3 Results 59 7.3.1 Causative variants in the “mono-allelic GJB2 variant” cohort 59 7.3.2 Causative variants in other deafness genes 59 7.3.3 Causative variants in GJB2 64 7.3.4 Causative variants in the “p.V37I” cohort 68 7.4 Discussion 72 8 Future work and perspective 76 References 78 著作 95 | |
dc.language.iso | en | |
dc.title | 應用次世代定序技術進行遺傳性聽力缺損之基因診斷 | zh_TW |
dc.title | Genetic Diagnosis of Hereditary Hearing Impairment via Next-generation Sequencing | en |
dc.type | Thesis | |
dc.date.schoolyear | 106-1 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 陳佑宗,吳振吉,陳倩瑜,許權振 | |
dc.subject.keyword | 遺傳性聽力缺損,聽損基因,基因檢測,次世代定序,生物資訊, | zh_TW |
dc.subject.keyword | hereditary hearing impairment,deafness gene,genetic testing,next-generation sequencing,bioinformatics, | en |
dc.relation.page | 98 | |
dc.identifier.doi | 10.6342/NTU201800090 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2018-01-18 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 基因體暨蛋白體醫學研究所 | zh_TW |
顯示於系所單位: | 基因體暨蛋白體醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-107-1.pdf 目前未授權公開取用 | 3.84 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。